Literature DB >> 3224472

Lewy body disease with and without dementia: a clinicopathological study of 35 cases.

K Kosaka1, K Tsuchiya, M Yoshimura.   

Abstract

The pathological basis for dementia in Lewy body disease (LBD) remains controversial. While some investigators propose that cortical lesions are responsible, others favor a subcortical basis for this dementia. Brains from 35 patients with LBD (11 demented with diffuse LBD; 12 demented and 12 non-demented with a brainstem type of LBD) were clinicopathologically examined to elucidate the pathological differences between demented and non-demented patients with LBD. In cases of diffuse LBD, the cortical lesions were found to be responsible for the dementia. In some of the cases (25%) with the brainstem type of LBD, the dementia was attributed to an Alzheimer pathology, while in many cases (75%), degeneration in the subcortical nuclei, mainly the nucleus basalis of Meynert, played a major role in the dementia.

Entities:  

Mesh:

Year:  1988        PMID: 3224472

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  26 in total

Review 1.  Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles.

Authors:  W Paulus; M Selim
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 2.  Diffuse Lewy body disease in Japan.

Authors:  K Kosaka
Journal:  J Neurol       Date:  1990-06       Impact factor: 4.849

Review 3.  Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases.

Authors:  Jing L Guo; Virginia M Y Lee
Journal:  Nat Med       Date:  2014-02       Impact factor: 53.440

Review 4.  Is Braak staging valid for all types of Parkinson's disease?

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2018-06-25       Impact factor: 3.575

5.  Neuropathological study on the nucleus basalis of Meynert in Pick's disease.

Authors:  K Mizukami; K Kosaka
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

Review 6.  Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Authors:  J A Obeso; M Stamelou; C G Goetz; W Poewe; A E Lang; D Weintraub; D Burn; G M Halliday; E Bezard; S Przedborski; S Lehericy; D J Brooks; J C Rothwell; M Hallett; M R DeLong; C Marras; C M Tanner; G W Ross; J W Langston; C Klein; V Bonifati; J Jankovic; A M Lozano; G Deuschl; H Bergman; E Tolosa; M Rodriguez-Violante; S Fahn; R B Postuma; D Berg; K Marek; D G Standaert; D J Surmeier; C W Olanow; J H Kordower; P Calabresi; A H V Schapira; A J Stoessl
Journal:  Mov Disord       Date:  2017-09       Impact factor: 10.338

7.  First neuropathological description of a patient with Parkinson's disease and LRRK2 p.N1437H mutation.

Authors:  Andreas Puschmann; Elisabet Englund; Owen A Ross; Carles Vilariño-Güell; Sarah J Lincoln; Jennifer M Kachergus; Stephanie A Cobb; Anna-Lena Törnqvist; Stig Rehncrona; Håkan Widner; Zbigniew K Wszolek; Matthew J Farrer; Christer Nilsson
Journal:  Parkinsonism Relat Disord       Date:  2011-12-06       Impact factor: 4.891

8.  New MRI Biomarkers Advance the Characterization of Parkinson Disease.

Authors:  David A Ziegler; Suzanne Corkin
Journal:  Eur Neurol Rev       Date:  2013

9.  Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's disease.

Authors:  Kolbjorn Bronnick; Murat Emre; Roger Lane; Sibel Tekin; Dag Aarsland
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-02-07       Impact factor: 10.154

Review 10.  Non Alzheimer's disease forms of cerebral atrophy.

Authors:  D Neary
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-11       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.